PMID: 9528823Apr 7, 1998Paper

Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not

Epidemiology and Infection
J M OssewaardeD Kromhout

Abstract

To test the hypothesis that chronic infection with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus is associated with coronary heart disease risk in elderly men, a nested case-control study in a cohort investigated in 1985 and 1990 in the town of Zutphen, The Netherlands, was designed. Fifty-four cases with a first diagnosed coronary event between 1985 and 1990, and 108 age-matched control subjects free of coronary heart disease during follow up were included in the study. The overall prevalence of antibodies to cytomegalovirus was 74.7%, to H. pylori 75.9% and to C. pneumoniae 84.0%. A high level of antibodies to C. pneumoniae was associated with an increased coronary heart disease risk (OR = 2.76; 95% CI = 1.31-5.81). This association was stronger in cases developing both myocardial infarction and angina pectoris, than in cases developing only one of these. This association was independent of potential confounders. Antibodies to cytomegalovirus or H. pylori were not associated with coronary heart disease risk. These results support the hypothesis of a role of chronic C. pneumoniae infections in the immunopathogenesis of atherosclerosis.

Citations

Feb 24, 2000·The Journal of Pathology·O J de BoerA E Becker
Sep 1, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E PodsiadłyS Tylewska-Wierzbanowska
Dec 21, 2000·Current Atherosclerosis Reports·J D Rutherford
Feb 2, 2002·Current Atherosclerosis Reports·Prediman K Shah
Aug 23, 2000·Current Cardiology Reports·C J O'Donnell, D Levy
Oct 28, 1999·American Heart Journal·P Saikku
Oct 25, 2000·Journal of Microbiological Methods·T TuuminenJ Paavonen
Dec 21, 2000·Journal of Microbiological Methods·J M OssewaardeJ Boman
Nov 11, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·C R Meier
Sep 7, 2000·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G CammarotaG Gasbarrini
Jun 6, 2000·The Journal of Infectious Diseases·J M Penninger, K Bachmaier
Jun 6, 2000·The Journal of Infectious Diseases·C R Meier
Jan 23, 1999·Current Opinion in Rheumatology·T JuvonenM J Savolainen
Mar 9, 2007·International Journal of Clinical Practice·E AltintasH Camdeviren
Jan 10, 2002·Clinical Microbiology Reviews·Jens Boman, Margaret R Hammerschlag
May 21, 1999·BMJ : British Medical Journal·R R West
Oct 21, 2000·Journal of Clinical Pathology·S A MorréH W Niessen
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Joseph B Muhlestein
Apr 18, 2009·Future Cardiology·Gregory J SeymourKazuhisa Yamazaki
Aug 21, 2013·Interdisciplinary Perspectives on Infectious Diseases·Hamidreza Honarmand
Aug 29, 2002·Helicobacter·Alberto Pilotto, Nathalie Salles
Mar 13, 2003·Mayo Clinic Proceedings·John P Higgins
Jun 26, 2003·Internal Medicine Journal·A G FraserR T Jackson
Jan 19, 2010·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Hem C JhaAruna Mittal
Jan 26, 2005·European Journal of Internal Medicine·P Järemo, A Richter
Nov 19, 2003·Cardiology Clinics·Joseph B Muhlestein, Jeffrey L Anderson
Oct 28, 1999·American Heart Journal·J G Kusters, E J Kuipers
Nov 4, 2000·Expert Opinion on Investigational Drugs·L Davydov, J W Cheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.